BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28416813)

  • 1. Brain-derived neurotrophic factor Val
    Wei SM; Baller EB; Kohn PD; Kippenhan JS; Kolachana B; Soldin SJ; Rubinow DR; Schmidt PJ; Berman KF
    Mol Psychiatry; 2018 Apr; 23(4):1066-1075. PubMed ID: 28416813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.
    Eisenberg DP; Ianni AM; Wei SM; Kohn PD; Kolachana B; Apud J; Weinberger DR; Berman KF
    Mol Psychiatry; 2013 Jun; 18(6):713-20. PubMed ID: 23319002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.
    Baller EB; Wei SM; Kohn PD; Rubinow DR; Alarcón G; Schmidt PJ; Berman KF
    Am J Psychiatry; 2013 Mar; 170(3):305-14. PubMed ID: 23361612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor Val⁶⁶Met polymorphism affects resting regional cerebral blood flow and functional connectivity differentially in women versus men.
    Wei SM; Eisenberg DP; Kohn PD; Kippenhan JS; Kolachana BS; Weinberger DR; Berman KF
    J Neurosci; 2012 May; 32(20):7074-81. PubMed ID: 22593075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks.
    Dennis NA; Cabeza R; Need AC; Waters-Metenier S; Goldstein DB; LaBar KS
    Hippocampus; 2011 Sep; 21(9):980-9. PubMed ID: 20865733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function.
    Spencer JL; Waters EM; Milner TA; Lee FS; McEwen BS
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4395-400. PubMed ID: 20142488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    Stonnington CM; Velgos SN; Chen Y; Syed S; Huentelman M; Thiyyagura P; Lee W; Richholt R; Caselli RJ; Locke DEC; Lu B; Reiman EM; Su Y; Chen K
    J Alzheimers Dis; 2020; 78(2):721-734. PubMed ID: 33044176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity.
    Hashimoto R; Moriguchi Y; Yamashita F; Mori T; Nemoto K; Okada T; Hori H; Noguchi H; Kunugi H; Ohnishi T
    Neurosci Res; 2008 Aug; 61(4):360-7. PubMed ID: 18501457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
    Egan MF; Kojima M; Callicott JH; Goldberg TE; Kolachana BS; Bertolino A; Zaitsev E; Gold B; Goldman D; Dean M; Lu B; Weinberger DR
    Cell; 2003 Jan; 112(2):257-69. PubMed ID: 12553913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.
    Ieraci A; Madaio AI; Mallei A; Lee FS; Popoli M
    Neuropsychopharmacology; 2016 Dec; 41(13):3070-3079. PubMed ID: 27388329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
    Gruber O; Hasan A; Scherk H; Wobrock T; Schneider-Axmann T; Ekawardhani S; Schmitt A; Backens M; Reith W; Meyer J; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):23-31. PubMed ID: 21509595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter volume in adolescent anxiety: an impact of the brain-derived neurotrophic factor Val(66)Met polymorphism?
    Mueller SC; Aouidad A; Gorodetsky E; Goldman D; Pine DS; Ernst M
    J Am Acad Child Adolesc Psychiatry; 2013 Feb; 52(2):184-95. PubMed ID: 23357445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
    Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.
    Bueller JA; Aftab M; Sen S; Gomez-Hassan D; Burmeister M; Zubieta JK
    Biol Psychiatry; 2006 May; 59(9):812-5. PubMed ID: 16442082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met Polymorphism Interacts with Sleep Consolidation to Predict Ability to Create New Declarative Memories.
    Gosselin N; De Beaumont L; Gagnon K; Baril AA; Mongrain V; Blais H; Montplaisir J; Gagnon JF; Pelleieux S; Poirier J; Carrier J
    J Neurosci; 2016 Aug; 36(32):8390-8. PubMed ID: 27511011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.
    Stern AJ; Savostyanova AA; Goldman A; Barnett AS; van der Veen JW; Callicott JH; Mattay VS; Weinberger DR; Marenco S
    Biol Psychiatry; 2008 Nov; 64(10):856-62. PubMed ID: 18707679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.
    Cerasa A; Tongiorgi E; Fera F; Gioia MC; Valentino P; Liguori M; Manna I; Zito G; Passamonti L; Nisticò R; Quattrone A
    Behav Brain Res; 2010 Mar; 207(2):377-86. PubMed ID: 19874854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.